Initiating systemic hormone therapy before age 50 years linked to increased risk for depression
Depression scores reduced significantly for single 25-mg dose versus 1-mg dose, but not for single 10-mg dose
However, treatment lowers risk of dementia among older adults
Estimated change from baseline in the PHQ-9 score increased with increasing work hours
However, only night sweats appear to be associated with stress scores
Authors say the health of family caregivers should be monitored in clinical practices
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years
Bilateral theta burst stimulation noninferior to standard bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression
Findings for pharmacotherapy, psychotherapy, or combination treatment
Additionally, decreases in satisfaction with work-life integration and increases in depression seen